Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Supporting Asian patients with metastatic breast cancer during ixabepilone therapy.

Bourdeanu L, Wong SF.

Expert Opin Drug Saf. 2010 May;9(3):383-96. doi: 10.1517/14740331003592082. Review.

PMID:
20105113
2.

Advances in breast cancer treatment: the emerging role of ixabepilone.

Frye DK.

Expert Rev Anticancer Ther. 2010 Jan;10(1):23-32. doi: 10.1586/era.09.158. Review.

PMID:
20014882
3.

Ixabepilone: a novel microtubule inhibitor for the treatment of locally advanced or metastatic breast cancer.

Steinberg M.

Clin Ther. 2008 Sep;30(9):1590-617. doi: 10.1016/j.clinthera.2008.09.015. Review.

PMID:
18840366
4.

Ixabepilone: a new antimitotic for the treatment of metastatic breast cancer.

Bhushan S, Walko CM.

Ann Pharmacother. 2008 Sep;42(9):1252-61. doi: 10.1345/aph.1L058. Epub 2008 Jul 22. Review.

PMID:
18648018
5.

Ixabepilone, a novel epothilone analog in the treatment of breast cancer.

Pivot X, Villanueva C, Chaigneau L, Nguyen T, Demarchi M, Maurina T, Stein U, Borg C.

Expert Opin Investig Drugs. 2008 Apr;17(4):593-9. doi: 10.1517/13543784.17.4.593 . Review.

PMID:
18363523
6.

Lapatinib and ixabepilone for the treatment of metastatic breast cancer.

Halterman PA.

Pharmacotherapy. 2008 Oct;28(10):1255-66. doi: 10.1592/phco.28.10.1255. Review.

PMID:
18823221
7.

Novel cytotoxic agents: epothilones.

Goodin S.

Am J Health Syst Pharm. 2008 May 15;65(10 Suppl 3):S10-5. doi: 10.2146/ajhp080089. Review.

PMID:
18463327
8.

Ixabepilone for the treatment of solid tumors: a review of clinical data.

Denduluri N, Swain SM.

Expert Opin Investig Drugs. 2008 Mar;17(3):423-35. doi: 10.1517/13543784.17.3.423 . Review.

PMID:
18321240
9.

Ixabepilone: a novel microtubule-stabilizing agent for the treatment of metastatic breast cancer.

Goodin S.

Am J Health Syst Pharm. 2008 Nov 1;65(21):2017-26. doi: 10.2146/ajhp070628. Review.

PMID:
18945860
10.

Efficacy of ixabepilone in ER/PR/HER2-negative (triple-negative) breast cancer.

Perez EA, Patel T, Moreno-Aspitia A.

Breast Cancer Res Treat. 2010 Jun;121(2):261-71. doi: 10.1007/s10549-010-0824-0. Epub 2010 Mar 13. Review.

PMID:
20229176
11.

Ixabepilone (Ixempra) for breast cancer.

[No authors listed]

Med Lett Drugs Ther. 2008 Jan 28;50(1278):7-8. No abstract available.

PMID:
18219261
12.

Epothilones in the treatment of cancer.

Larkin JM, Kaye SB.

Expert Opin Investig Drugs. 2006 Jun;15(6):691-702. Review.

PMID:
16732719
13.

Clinical development of ixabepilone and other epothilones in patients with advanced solid tumors.

Rivera E, Lee J, Davies A.

Oncologist. 2008 Dec;13(12):1207-23. doi: 10.1634/theoncologist.2008-0143. Epub 2008 Dec 16. Review.

14.

Integrating epothilones into the treatment of patients with metastatic breast cancer: clinical perspectives on incorporating recent data in the practice setting.

Cigler T, Vahdat L.

Clin Breast Cancer. 2008 Dec;8 Suppl 4:S166-70. doi: 10.3816/CBC.2008.s.013. Review.

PMID:
19158037
15.

Ixabepilone and other epothilones: microtubule-targeting agents for metastatic breast cancer.

Morris PG, Fornier MN.

Clin Adv Hematol Oncol. 2009 Feb;7(2):115-22.

PMID:
19367253
16.

Global experience with ixabepilone in breast cancer.

Kaklamani VG, Xu BH, Gomez HL.

Expert Rev Anticancer Ther. 2011 May;11(5):683-92. doi: 10.1586/era.11.41. Review.

PMID:
21554041
17.

Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in patients with taxane-resistant metastatic breast cancer.

Thomas E, Tabernero J, Fornier M, Conté P, Fumoleau P, Lluch A, Vahdat LT, Bunnell CA, Burris HA, Viens P, Baselga J, Rivera E, Guarneri V, Poulart V, Klimovsky J, Lebwohl D, Martin M.

J Clin Oncol. 2007 Aug 10;25(23):3399-406. Epub 2007 Jul 2.

PMID:
17606975
18.

Epothilones in breast cancer: current status and future directions.

Atzori F, Fornier M.

Expert Rev Anticancer Ther. 2008 Aug;8(8):1299-311. doi: 10.1586/14737140.8.8.1299. Review.

PMID:
18699766
19.

Phase II genomics study of ixabepilone as neoadjuvant treatment for breast cancer.

Baselga J, Zambetti M, Llombart-Cussac A, Manikhas G, Kubista E, Steger GG, Makhson A, Tjulandin S, Ludwig H, Verrill M, Ciruelos E, Egyhazi S, Xu LA, Zerba KE, Lee H, Clark E, Galbraith S.

J Clin Oncol. 2009 Feb 1;27(4):526-34. doi: 10.1200/JCO.2007.14.2646. Epub 2008 Dec 15.

PMID:
19075286
20.

Nail disorders in a woman treated with ixabepilone for metastatic breast cancer.

Alimonti A, Nardoni C, Papaldo P, Ferretti G, Caleno MP, Carlini P, Fabi A, Rasio D, Vecchione A, Cognetti F.

Anticancer Res. 2005 Sep-Oct;25(5):3531-2.

Supplemental Content

Support Center